VIDEO: Risankizumab linked to lower risk of serious infection than other systemic treatments
- Jeremy Visser
- May 13
- 1 min read
According to a recent study, risankizumab was associated with a lower risk of serious infections when compared to other systemic treatments for psoriasis.
Comments